GL1X · GenesisL1 explorer

MolNFT v1 · #73957 · protein

Crystal structure of enoyl-acp reductases I (fabi) from B. subtilis (complex with NAD and inh)

3OIG · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Crystal structure of enoyl-acp reductases I (fabi) from B. subtilis (complex with NAD and inh)”. X-ray diffraction, 2 ligands (NAD, IMJ), 2 pockets (best druggability 0.79). MolNFT v1…

PDB
3OIG
Type
protein
Length
260 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P54616
Ligands
NAD, IMJ
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26049% helix, 15% strandP54616

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • IMJ · (2E)-N-[(1,2-dimethyl-1H-indol-3-yl)methyl]-N-methyl-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)prop-2-enamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16090.790.8448NAD, IMJ
2620.390.8021empty

Compared structures

  • 3OIG · Crystal Structure of Enoyl-ACP Reductases I (FabI) from B. subtilis (complex with NAD and… · the same entry in another collection · chain A against A, TM-score 1.00
  • P54616 · AlphaFold monomer V2.0 prediction for enoyl-[acyl-carrier-protein] reductase [NADH] fabi… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.